Kondo M, Kojima S, Kato K, Matsuyama T
Division of Hematology/Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital.
Bone Marrow Transplant. 1998 Nov;22(10):995-8. doi: 10.1038/sj.bmt.1701482.
We analyzed the incidence, complications, and risk factors for late-onset hemorrhagic cystitis (HC) in 256 children undergoing hematopoietic stem cell transplantation (HSCT). Twenty-six recipients (10.2%) developed late-onset HC between 3 and 270 days (median, 33 days) after HSCT. In most patients, the severity of HC was mild to moderate, and spontaneous resolution occurred. Three children developed bladder tamponade, and one required suprapubic cystotomy. Four children died in the early post-transplant period without resolution of HC, but HC was not the direct cause of death in any patient. Twenty-two patients recovered within 6-86 days (median, 16 days) of onset. Three predisposing factors were identified for development of late-onset HC by multivariate analysis: allogeneic HSCT, older age (> or = 7 years), and busulphan for pretransplant conditioning were significantly associated with late-onset HC (P=0.022, P=0.044 and P=0.036, respectively). Excretion of adenovirus type 11 was demonstrated in six of 22 patients at the onset of cystitis. We suspect that reactivation of virus may be a major pathogenic factor in late-onset HC, but several clinical factors are also associated.
我们分析了256例接受造血干细胞移植(HSCT)的儿童迟发性出血性膀胱炎(HC)的发病率、并发症及危险因素。26例受者(10.2%)在HSCT后3至270天(中位数为33天)发生迟发性HC。大多数患者HC的严重程度为轻至中度,且可自发缓解。3例儿童出现膀胱填塞,1例需要耻骨上膀胱切开术。4例儿童在移植后早期死亡,HC未缓解,但HC并非任何患者的直接死因。22例患者在发病后6至86天(中位数为16天)内康复。多因素分析确定了迟发性HC发生的3个易感因素:异基因HSCT、年龄较大(≥7岁)以及移植前预处理使用白消安与迟发性HC显著相关(P分别为0.022、0.044和0.036)。22例膀胱炎发病患者中有6例检测到11型腺病毒排泄。我们怀疑病毒再激活可能是迟发性HC的主要致病因素,但也与一些临床因素有关。